BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32041716)

  • 1. Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus.
    Raynaud C; Daher W; Roquet-Banères F; Johansen MD; Stec J; Onajole OK; Ordway D; Kozikowski AP; Kremer L
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32041716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex
    Pandey R; Chen L; Manca C; Jenkins S; Glaser L; Vinnard C; Stone G; Lee J; Mathema B; Nuermberger EL; Bonomo RA; Kreiswirth BN
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
    Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
    J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Select β-Lactam Combinations Exhibit Synergy against
    Story-Roller E; Maggioncalda EC; Lamichhane G
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745389
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease.
    Pozuelo Torres M; van Ingen J
    Clin Microbiol Infect; 2024 Jun; 30(6):738-742. PubMed ID: 38527611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Efficacy of β-Lactam Combinations against
    Story-Roller E; Maggioncalda EC; Lamichhane G
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109979
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745387
    [No Abstract]   [Full Text] [Related]  

  • 8.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kaushik A; Ammerman NC; Lee J; Martins O; Kreiswirth BN; Lamichhane G; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole-2-Carboxamides Are Active against
    Pandya AN; Prathipati PK; Hegde P; Li W; Graham KF; Mandal S; Drescher KM; Destache CJ; Ordway D; Jackson M; North EJ
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602519
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Chen L; Shashkina E; Kurepina N; Calado Nogueira de Moura V; Daley CL; Kreiswirth BN
    Antimicrob Agents Chemother; 2024 May; 68(5):e0017424. PubMed ID: 38557171
    [No Abstract]   [Full Text] [Related]  

  • 12. Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus.
    Lindman M; Dick T
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182531
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Yamatani I; Aono A; Fujiwara K; Asami T; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Komiya K; Mitarai S
    Microbiol Spectr; 2024 Jul; 12(7):e0008424. PubMed ID: 38842354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex.
    Lavollay M; Dubée V; Heym B; Herrmann JL; Gaillard JL; Gutmann L; Arthur M; Mainardi JL
    Clin Microbiol Infect; 2014 May; 20(5):O297-300. PubMed ID: 24112243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "One-Two Punch": Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis Enzymes.
    Nguyen DC; Dousa KM; Kurz SG; Brown ST; Drusano G; Holland SM; Kreiswirth BN; Boom WH; Daley CL; Bonomo RA
    Clin Infect Dis; 2021 Oct; 73(8):1532-1536. PubMed ID: 34113990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the intracellular activity of drugs against Mycobacterium abscessus using a THP-1 macrophage model.
    Molina-Torres CA; Tamez-Peña L; Castro-Garza J; Ocampo-Candiani J; Vera-Cabrera L
    J Microbiol Methods; 2018 May; 148():29-32. PubMed ID: 29626567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex.
    Zhang Z; Lu J; Song Y; Pang Y
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):31-34. PubMed ID: 29089153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal and intracellular activity of β-lactams against Mycobacterium abscessus.
    Lefebvre AL; Dubée V; Cortes M; Dorchêne D; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2016 Jun; 71(6):1556-63. PubMed ID: 26929268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M; Burian J; Thompson CJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [No Abstract]   [Full Text] [Related]  

  • 20. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
    Viljoen A; Raynaud C; Johansen MD; Roquet-Banères F; Herrmann JL; Daher W; Kremer L
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.